Detalhe da pesquisa
1.
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins.
Sci Rep
; 14(1): 5095, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429374